Synergistic Effects on Taurine and Cisplatin on Lung Cancer Cells (A549) (vol 57, pg 193, 2023)

被引:1
作者
Jouni, Fatemeh Javani [1 ]
Zafari, Jaber [2 ]
Abbasifard, Mitra [3 ]
Jafarisani, Moslem [4 ]
Sadeghi, Hanieh [5 ]
Bagheri-Hosseinabadi, Zahra [6 ,7 ]
机构
[1] Islamic Azad Univ, Fac Adv Sci & Technol, Dept Biochem & Biophys, Tehran Med Sci, Tehran, Iran
[2] Islamic Azad Univ, Fac Pharm, Dept Pharmacol & Toxicol, Tehran Med Sci, Tehran, Iran
[3] Rafsanjan Univ Med Sci, Ali Ibn Abi Talib Hosp, Sch Med, Dept Internal Med, Rafsanjan, Iran
[4] Shahroud Univ Med Sci, Sch Med, Shahroud, Iran
[5] Shahid Beheshti Univ Med Sci, Laser Applicat Med Sci Res Ctr, Tehran, Iran
[6] Rafsanjan Univ Med Sci, Res Inst Basic Med Sci, Physiol Pharmacol Res Ctr, Rafsanjan, Iran
[7] Rafsanjan Univ Med Sci, Sch Med, Dept Clin Biochem, Rafsanjan, Iran
关键词
SURVIVORSHIP STATISTICS; CELLULAR PHARMACOLOGY; BREAST-CANCER; COPPER; RESISTANCE; APOPTOSIS; CTR1; VIEW;
D O I
10.3103/S0095452723040047
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
An Erratum to this paper has been published: https://doi.org/10.3103/S0095452723040047
引用
收藏
页码:384 / 385
页数:2
相关论文
共 27 条
  • [1] An Updated View of Cisplatin Transport
    Arnesano, Fabio
    Losacco, Maurizio
    Natile, Giovanni
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2013, (15) : 2701 - 2711
  • [2] Cellular Responses to Cisplatin-Induced DNA Damage
    Basu, Alakananda
    Krishnamurthy, Soumya
    [J]. JOURNAL OF NUCLEIC ACIDS, 2010, 2010
  • [3] Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells
    Beretta, GL
    Gatti, L
    Tinelli, S
    Corna, E
    Colangelo, D
    Zunino, F
    Perego, P
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (02) : 283 - 291
  • [4] Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
    Chen, D.
    Milacic, Vesna
    Frezza, Michael
    Dou, Q. Ping
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 777 - 791
  • [5] Taurine protects cisplatin induced cardiotoxicity by modulating inflammatory and endoplasmic reticulum stress responses
    Chowdhury, Sayantani
    Sinha, Krishnendu
    Banerjee, Sharmistha
    Sil, Parames C.
    [J]. BIOFACTORS, 2016, 42 (06) : 647 - 664
  • [6] Taurine: a novel tumor marker for enhanced detection of breast cancer among female patients
    El Agouza, I. M.
    Eissa, S. S.
    El Houseini, M. M.
    El-Nashar, Dalia E.
    Abd El Hameed, O. M.
    [J]. ANGIOGENESIS, 2011, 14 (03) : 321 - 330
  • [7] Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351
  • [8] Molecular mechanisms of cisplatin resistance
    Galluzzi, L.
    Senovilla, L.
    Vitale, I.
    Michels, J.
    Martins, I.
    Kepp, O.
    Castedo, M.
    Kroemer, G.
    [J]. ONCOGENE, 2012, 31 (15) : 1869 - 1883
  • [9] Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells
    Holzer, AK
    Katano, K
    Klomp, LWJ
    Howell, SB
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (19) : 6744 - 6749
  • [10] Jalali A., 2019, COMBINATION STATIC M, P1